메뉴 건너뛰기




Volumn 68, Issue 11, 2016, Pages 1579-1590

Development of the American College of Rheumatology’s Rheumatoid Arthritis Electronic Clinical Quality Measures

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; ANTIRHEUMATIC AGENT;

EID: 84992456269     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22984     Document Type: Article
Times cited : (49)

References (41)
  • 1
    • 84924021246 scopus 로고    scopus 로고
    • Measure Prioritization Advisory Committee Report
    • National Quality Forum. Measure Prioritization Advisory Committee Report. Prioritization of high-impact Medicare conditions and measure gaps. 2010 URL: http://www.qualityforum.org/projects/prioritization.aspx.
    • (2010) Prioritization of high-impact Medicare conditions and measure gaps
  • 2
    • 38149138096 scopus 로고    scopus 로고
    • Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I
    • Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 2008;58:15–25.
    • (2008) Arthritis Rheum , vol.58 , pp. 15-25
    • Helmick, C.G.1    Felson, D.T.2    Lawrence, R.C.3    Gabriel, S.4    Hirsch, R.5    Kwoh, C.K.6
  • 3
    • 79551564550 scopus 로고    scopus 로고
    • Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans
    • Schmajuk G, Trivedi AN, Solomon DH, Yelin E, Trupin L, Chakravarty EF, et al. Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans. JAMA 2011;305:480–6.
    • (2011) JAMA , vol.305 , pp. 480-486
    • Schmajuk, G.1    Trivedi, A.N.2    Solomon, D.H.3    Yelin, E.4    Trupin, L.5    Chakravarty, E.F.6
  • 4
    • 82455163777 scopus 로고    scopus 로고
    • Quality measurement and improvement in rheumatology: rheumatoid arthritis as a case study
    • Desai SP, Yazdany J. Quality measurement and improvement in rheumatology: rheumatoid arthritis as a case study. Arthritis Rheum 2011;63:3649–60.
    • (2011) Arthritis Rheum , vol.63 , pp. 3649-3660
    • Desai, S.P.1    Yazdany, J.2
  • 5
    • 84988975701 scopus 로고    scopus 로고
    • Methods for Developing the American College of Rheumatology's Electronic Clinical Quality Measures
    • Yazdany J, Myslinski R, Miller A, Francisco M, Desai S, Schmajuk, et al. Methods for Developing the American College of Rheumatology's Electronic Clinical Quality Measures. Arthritis Care Res (Hoboken) 2016;68:1402–9.
    • (2016) Arthritis Care Res (Hoboken) , vol.68 , pp. 1402-1409
    • Yazdany, J.1    Myslinski, R.2    Miller, A.3    Francisco, M.4    Desai, S.5    Schmajuk6
  • 6
    • 84859832981 scopus 로고    scopus 로고
    • 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
    • Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012;64:625–39.
    • (2012) Arthritis Care Res (Hoboken) , vol.64 , pp. 625-639
    • Singh, J.A.1    Furst, D.E.2    Bharat, A.3    Curtis, J.R.4    Kavanaugh, A.F.5    Kremer, J.M.6
  • 7
    • 1842780872 scopus 로고    scopus 로고
    • Measuring quality in arthritis care: methods for developing the Arthritis Foundation's quality indicator set
    • MacLean CH, Saag KG, Solomon DH, Morton SC, Sampsel S, Klippel JH. Measuring quality in arthritis care: methods for developing the Arthritis Foundation's quality indicator set. Arthritis Rheum 2004;51:193–202.
    • (2004) Arthritis Rheum , vol.51 , pp. 193-202
    • MacLean, C.H.1    Saag, K.G.2    Solomon, D.H.3    Morton, S.C.4    Sampsel, S.5    Klippel, J.H.6
  • 8
    • 0002241269 scopus 로고
    • The RAND/UCLA appropriateness method
    • In, McCormick KA, Moore SR, Siegel RA, eds., Rockville (MD) Public Health Service, U.S. Department of Health and Human Services
    • Brook RH. The RAND/UCLA appropriateness method. In: McCormick KA, Moore SR, Siegel RA, eds. Methodology perspectives, AHCPR Pub No. 95-009, Rockville (MD) Public Health Service, U.S. Department of Health and Human Services; 1994. pp. 59–70.
    • (1994) Methodology perspectives, AHCPR Pub No. 95-009 , pp. 59-70
    • Brook, R.H.1
  • 9
    • 84992466417 scopus 로고    scopus 로고
    • National Quality Forum. Quality data model. 2012. URL: https://ecqi.healthit.gov/system/files/qdm/qdm_122012.pdf
    • (2012)
  • 10
    • 77950309959 scopus 로고    scopus 로고
    • Evidence for treating rheumatoid arthritis to target: results of a systematic literature search
    • Schoels M, Knevel R, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas DT, et al. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search. Ann Rheum Dis 2010;69:638–43.
    • (2010) Ann Rheum Dis , vol.69 , pp. 638-643
    • Schoels, M.1    Knevel, R.2    Aletaha, D.3    Bijlsma, J.W.4    Breedveld, F.C.5    Boumpas, D.T.6
  • 12
    • 3242677099 scopus 로고    scopus 로고
    • Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial
    • Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004;364:263–9.
    • (2004) Lancet , vol.364 , pp. 263-269
    • Grigor, C.1    Capell, H.2    Stirling, A.3    McMahon, A.D.4    Lock, P.5    Vallance, R.6
  • 13
    • 35648991026 scopus 로고    scopus 로고
    • Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)
    • Verstappen SM, Jacobs JW, van der Veen MJ, Heurkens AH, Schenk Y, ter Borg EJ, et al. Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis 2007;66:1443–9.
    • (2007) Ann Rheum Dis , vol.66 , pp. 1443-1449
    • Verstappen, S.M.1    Jacobs, J.W.2    van der Veen, M.J.3    Heurkens, A.H.4    Schenk, Y.5    ter Borg, E.J.6
  • 14
    • 23944447850 scopus 로고    scopus 로고
    • Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial
    • Fransen J, Moens HB, Speyer I, van Riel PL. Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial. Ann Rheum Dis 2005;64:1294–8.
    • (2005) Ann Rheum Dis , vol.64 , pp. 1294-1298
    • Fransen, J.1    Moens, H.B.2    Speyer, I.3    van Riel, P.L.4
  • 15
    • 85045416849 scopus 로고    scopus 로고
    • The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis
    • Symmons D, Tricker K, Roberts C, Davies L, Dawes P, Scott DL. The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis. Health Technol Assess 2005;9:iii–iv, ix–x, 1–78.
    • (2005) Health Technol Assess , vol.9
    • Symmons, D.1    Tricker, K.2    Roberts, C.3    Davies, L.4    Dawes, P.5    Scott, D.L.6
  • 16
    • 84959331287 scopus 로고    scopus 로고
    • Effects of achieving target measures in rheumatoid arthritis on functional status, quality of life, and resource utilization: analysis of clinical practice data
    • Alemao E, Joo S, Kawabata H, Al MJ, Allison PD, Rutten-van Molken MP, et al. Effects of achieving target measures in rheumatoid arthritis on functional status, quality of life, and resource utilization: analysis of clinical practice data. Arthritis Care Res (Hoboken) 2016;68:308–17.
    • (2016) Arthritis Care Res (Hoboken) , vol.68 , pp. 308-317
    • Alemao, E.1    Joo, S.2    Kawabata, H.3    Al, M.J.4    Allison, P.D.5    Rutten-van Molken, M.P.6
  • 17
    • 84925389993 scopus 로고    scopus 로고
    • Improving the quality of care of patients with rheumatic disease using patient-centric electronic redesign software
    • Newman ED, Lerch V, Billet J, Berger A, Kirchner HL. Improving the quality of care of patients with rheumatic disease using patient-centric electronic redesign software. Arthritis Care Res (Hoboken) 2015;67:546–53.
    • (2015) Arthritis Care Res (Hoboken) , vol.67 , pp. 546-553
    • Newman, E.D.1    Lerch, V.2    Billet, J.3    Berger, A.4    Kirchner, H.L.5
  • 18
    • 84859853303 scopus 로고    scopus 로고
    • Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice
    • Anderson J, Caplan L, Yazdany J, Robbins ML, Neogi T, Michaud K, et al. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res (Hoboken) 2012;64:640–7.
    • (2012) Arthritis Care Res (Hoboken) , vol.64 , pp. 640-647
    • Anderson, J.1    Caplan, L.2    Yazdany, J.3    Robbins, M.L.4    Neogi, T.5    Michaud, K.6
  • 20
    • 84888086202 scopus 로고    scopus 로고
    • Racial and ethnic disparities in disease activity in patients with rheumatoid arthritis
    • Greenberg JD, Spruill TM, Shan Y, Reed G, Kremer JM, Potter J, et al. Racial and ethnic disparities in disease activity in patients with rheumatoid arthritis. Am J Med 2013;126:1089–98.
    • (2013) Am J Med , vol.126 , pp. 1089-1098
    • Greenberg, J.D.1    Spruill, T.M.2    Shan, Y.3    Reed, G.4    Kremer, J.M.5    Potter, J.6
  • 21
    • 80755180999 scopus 로고    scopus 로고
    • Measures of functional status and quality of life in rheumatoid arthritis: Health Assessment Questionnaire Disability Index (HAQ), Modified Health Assessment Questionnaire (MHAQ), Multidimensional Health Assessment Questionnaire (MDHAQ), Health Assessment Questionnaire II (HAQ-II), Improved Health Assessment Questionnaire (Improved HAQ), and Rheumatoid Arthritis Quality of Life (RAQoL)
    • Maska L, Anderson J, Michaud K. Measures of functional status and quality of life in rheumatoid arthritis: Health Assessment Questionnaire Disability Index (HAQ), Modified Health Assessment Questionnaire (MHAQ), Multidimensional Health Assessment Questionnaire (MDHAQ), Health Assessment Questionnaire II (HAQ-II), Improved Health Assessment Questionnaire (Improved HAQ), and Rheumatoid Arthritis Quality of Life (RAQoL). Arthritis Care Res (Hoboken) 2011;63 Suppl 11:S4–13.
    • (2011) Arthritis Care Res (Hoboken) , vol.63 , pp. S4-13
    • Maska, L.1    Anderson, J.2    Michaud, K.3
  • 22
    • 84897974614 scopus 로고    scopus 로고
    • Development of patient-centred standards of care for rheumatoid arthritis in Europe: the eumusc.net project
    • Stoffer MA, Smolen JS, Woolf A, Ambrozic A, Bosworth A, Carmona L, et al. Development of patient-centred standards of care for rheumatoid arthritis in Europe: the eumusc.net project. Ann Rheum Dis 2014;73:902–5.
    • (2014) Ann Rheum Dis , vol.73 , pp. 902-905
    • Stoffer, M.A.1    Smolen, J.S.2    Woolf, A.3    Ambrozic, A.4    Bosworth, A.5    Carmona, L.6
  • 23
    • 84893772728 scopus 로고    scopus 로고
    • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
    • Smolen JS, Landewe R, Breedveld FC, Buch M, Burmester G, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 2014;73:492–509.
    • (2014) Ann Rheum Dis , vol.73 , pp. 492-509
    • Smolen, J.S.1    Landewe, R.2    Breedveld, F.C.3    Buch, M.4    Burmester, G.5    Dougados, M.6
  • 24
    • 84864570470 scopus 로고    scopus 로고
    • Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs
    • Bykerk VP, Akhavan P, Hazlewood GS, Schieir O, Dooley A, Haraoui B, et al. Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs. J Rheumatol 2012;39:559–82.
    • (2012) J Rheumatol , vol.39 , pp. 559-582
    • Bykerk, V.P.1    Akhavan, P.2    Hazlewood, G.S.3    Schieir, O.4    Dooley, A.5    Haraoui, B.6
  • 25
    • 84875774711 scopus 로고    scopus 로고
    • Continuous innovation: developing and using a clinical database with new technology for patient-centred care: the case of the Swedish quality register for arthritis
    • Ovretveit J, Keller C, Hvitfeldt Forsberg H, Essen A, Lindblad S, Brommels M. Continuous innovation: developing and using a clinical database with new technology for patient-centred care: the case of the Swedish quality register for arthritis. Int J Qual Health Care 2013;25:118–24.
    • (2013) Int J Qual Health Care , vol.25 , pp. 118-124
    • Ovretveit, J.1    Keller, C.2    Hvitfeldt Forsberg, H.3    Essen, A.4    Lindblad, S.5    Brommels, M.6
  • 26
    • 80054108467 scopus 로고    scopus 로고
    • MDHAQ/RAPID3 scores: quantitative patient history data in a standardized “scientific” format for optimal assessment of patient status and quality of care in rheumatic diseases
    • Pincus T, Castrejon I. MDHAQ/RAPID3 scores: quantitative patient history data in a standardized “scientific” format for optimal assessment of patient status and quality of care in rheumatic diseases. Bull NYU Hosp Jt Dis 2011;69:201–14.
    • (2011) Bull NYU Hosp Jt Dis , vol.69 , pp. 201-214
    • Pincus, T.1    Castrejon, I.2
  • 27
    • 84929941910 scopus 로고    scopus 로고
    • Use of clinical scores to guide therapeutic decisions in patients with rheumatoid arthritis in daily care
    • Malysheva O, Bedrich A, Kuipers JG, Kleine H, Wolff B, Baerwald CG. Use of clinical scores to guide therapeutic decisions in patients with rheumatoid arthritis in daily care. Clin Exp Rheumatol 2015;33:255–8.
    • (2015) Clin Exp Rheumatol , vol.33 , pp. 255-258
    • Malysheva, O.1    Bedrich, A.2    Kuipers, J.G.3    Kleine, H.4    Wolff, B.5    Baerwald, C.G.6
  • 28
    • 84918783617 scopus 로고    scopus 로고
    • Responsiveness and minimally important difference for the patient-reported outcomes measurement information system (PROMIS) 20-item physical functioning short form in a prospective observational study of rheumatoid arthritis
    • Hays RD, Spritzer KL, Fries JF, Krishnan E. Responsiveness and minimally important difference for the patient-reported outcomes measurement information system (PROMIS) 20-item physical functioning short form in a prospective observational study of rheumatoid arthritis. Ann Rheum Dis 2015;74:104–7.
    • (2015) Ann Rheum Dis , vol.74 , pp. 104-107
    • Hays, R.D.1    Spritzer, K.L.2    Fries, J.F.3    Krishnan, E.4
  • 29
    • 79961101822 scopus 로고    scopus 로고
    • The PROMIS of better outcome assessment: responsiveness, floor and ceiling effects, and Internet administration
    • Fries J, Rose M, Krishnan E. The PROMIS of better outcome assessment: responsiveness, floor and ceiling effects, and Internet administration. J Rheumatol 2011;38:1759–64.
    • (2011) J Rheumatol , vol.38 , pp. 1759-1764
    • Fries, J.1    Rose, M.2    Krishnan, E.3
  • 30
    • 70349254791 scopus 로고    scopus 로고
    • Progress in assessing physical function in arthritis: PROMIS short forms and computerized adaptive testing
    • Fries JF, Cella D, Rose M, Krishnan E, Bruce B. Progress in assessing physical function in arthritis: PROMIS short forms and computerized adaptive testing. J Rheumatol 2009;36:2061–6.
    • (2009) J Rheumatol , vol.36 , pp. 2061-2066
    • Fries, J.F.1    Cella, D.2    Rose, M.3    Krishnan, E.4    Bruce, B.5
  • 31
    • 80052658287 scopus 로고    scopus 로고
    • Improved responsiveness and reduced sample size requirements of PROMIS physical function scales with item response theory
    • Fries JF, Krishnan E, Rose M, Lingala B, Bruce B. Improved responsiveness and reduced sample size requirements of PROMIS physical function scales with item response theory. Arthritis Res Ther 2011;13:R147.
    • (2011) Arthritis Res Ther , vol.13 , pp. R147
    • Fries, J.F.1    Krishnan, E.2    Rose, M.3    Lingala, B.4    Bruce, B.5
  • 32
    • 77953706155 scopus 로고    scopus 로고
    • Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis
    • Gaujoux-Viala C, Smolen JS, Landewe R, Dougados M, Kvien TK, Mola EM, et al. Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 2010;69:1004–9.
    • (2010) Ann Rheum Dis , vol.69 , pp. 1004-1009
    • Gaujoux-Viala, C.1    Smolen, J.S.2    Landewe, R.3    Dougados, M.4    Kvien, T.K.5    Mola, E.M.6
  • 34
    • 68049113582 scopus 로고    scopus 로고
    • Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug–free remission in rheumatoid arthritis: results from two large early arthritis cohorts
    • Van der Woude D, Young A, Jayakumar K, Mertens BJ, Toes RE, van der Heijde D, et al. Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug–free remission in rheumatoid arthritis: results from two large early arthritis cohorts. Arthritis Rheum 2009;60:2262–71.
    • (2009) Arthritis Rheum , vol.60 , pp. 2262-2271
    • Van der Woude, D.1    Young, A.2    Jayakumar, K.3    Mertens, B.J.4    Toes, R.E.5    van der Heijde, D.6
  • 35
    • 84889034482 scopus 로고    scopus 로고
    • Patterns of disease-modifying antirheumatic drug use in rheumatoid arthritis patients after 2002: a systematic review
    • Schmajuk G, Solomon DH, Yazdany J. Patterns of disease-modifying antirheumatic drug use in rheumatoid arthritis patients after 2002: a systematic review. Arthritis Care Res (Hoboken) 2013;65:1927–35.
    • (2013) Arthritis Care Res (Hoboken) , vol.65 , pp. 1927-1935
    • Schmajuk, G.1    Solomon, D.H.2    Yazdany, J.3
  • 36
    • 84908544676 scopus 로고    scopus 로고
    • Receipt of glucocorticoid monotherapy among Medicare beneficiaries with rheumatoid arthritis
    • Yazdany J, Tonner C, Schmajuk G, Lin GA, Trivedi AN. Receipt of glucocorticoid monotherapy among Medicare beneficiaries with rheumatoid arthritis. Arthritis Care Res (Hoboken) 2014;66:1447–55.
    • (2014) Arthritis Care Res (Hoboken) , vol.66 , pp. 1447-1455
    • Yazdany, J.1    Tonner, C.2    Schmajuk, G.3    Lin, G.A.4    Trivedi, A.N.5
  • 37
    • 27744485375 scopus 로고    scopus 로고
    • American Thoracic Society; Centers for Disease Control and Prevention; Infectious Diseases Society of America. Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America
    • Taylor Z, Nolan CM, Blumberg HM; American Thoracic Society; Centers for Disease Control and Prevention; Infectious Diseases Society of America. Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Recomm Rep 2005;54:1–81.
    • (2005) MMWR Recomm Rep , vol.54 , pp. 1-81
    • Taylor, Z.1    Nolan, C.M.2    Blumberg, H.M.3
  • 38
    • 0033524159 scopus 로고    scopus 로고
    • Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group
    • Maini R, St.Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, et al. Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group. Lancet 1999;354:932–9.
    • (1999) Lancet , vol.354 , pp. 932-939
    • Maini, R.1    St.Clair, E.W.2    Breedveld, F.3    Furst, D.4    Kalden, J.5    Weisman, M.6
  • 40
    • 84941588323 scopus 로고    scopus 로고
    • Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis
    • Winthrop KL, Park SH, Gul A, Cardiel MH, Gomez-Reino JJ, Tanaka Y, et al. Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis. Ann Rheum Dis 2016;75:1133–8.
    • (2016) Ann Rheum Dis , vol.75 , pp. 1133-1138
    • Winthrop, K.L.1    Park, S.H.2    Gul, A.3    Cardiel, M.H.4    Gomez-Reino, J.J.5    Tanaka, Y.6
  • 41
    • 77953994043 scopus 로고    scopus 로고
    • Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection: United States, 2010
    • Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K, et al. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection: United States, 2010. MMWR Recomm Rep 2010;59:1–25.
    • (2010) MMWR Recomm Rep , vol.59 , pp. 1-25
    • Mazurek, G.H.1    Jereb, J.2    Vernon, A.3    LoBue, P.4    Goldberg, S.5    Castro, K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.